- Home
- IDN vs COEP Comparison
IDN vs COEP Comparison
Compare IDN & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IDN | COEP |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.6M | 100.4M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | IDN | COEP |
|---|---|---|
| Price | $4.85 | $12.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 150.4K | 44.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,433,454.00 | N/A |
| Revenue This Year | $12.21 | N/A |
| Revenue Next Year | $12.44 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.21 | N/A |
| 52 Week Low | $2.24 | $6.32 |
| 52 Week High | $7.48 | $21.41 |
Technical Indicators
Market Signals| Indicator | IDN | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 38.19 | 41.31 |
| Support Level | $4.56 | $10.74 |
| Resistance Level | $5.01 | $12.71 |
| Average True Range (ATR) | 0.23 | 0.80 |
| MACD | 0.04 | 0.09 |
| Stochastic Oscillator | 39.58 | 37.26 |
Price Performance
Historical ComparisonAbout IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.